146 related articles for article (PubMed ID: 11361665)
1. Crixivan reduces viral load.
AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361665
[No Abstract] [Full Text] [Related]
2. Merck protease inhibitor: more news from Retroviruses Conference.
James JS
AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head study of protease inhibitors.
AIDS Patient Care STDS; 1998 Jan; 12(1):63-4. PubMed ID: 11361890
[No Abstract] [Full Text] [Related]
4. Update on HIV protease inhibitors.
Vella S
AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
[TBL] [Abstract][Full Text] [Related]
5. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA
An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297
[TBL] [Abstract][Full Text] [Related]
6. Undetectable HIV levels after triple therapy with indinavir.
AIDS Patient Care STDS; 1997 Jun; 11(3):193-4. PubMed ID: 11361795
[No Abstract] [Full Text] [Related]
7. No more twice-a-day Crixivan.
Vazquez E
Posit Aware; 1998; 9(6):17. PubMed ID: 11366469
[TBL] [Abstract][Full Text] [Related]
8. Twice-a-day Crixivan study discontinued.
Newsline People AIDS Coalit N Y; 1998; ():31. PubMed ID: 11367502
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitor combination.
AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361664
[No Abstract] [Full Text] [Related]
10. [HIV: less resistance due to combined treatment].
Dtsch Med Wochenschr; 1996 Dec; 121(49):A47-8. PubMed ID: 8998914
[No Abstract] [Full Text] [Related]
11. Merck pushes the envelope with once-daily indinavir.
TreatmentUpdate; 2001; 12(12):8. PubMed ID: 11570096
[No Abstract] [Full Text] [Related]
12. Twice daily Indinavir trial stopped.
TreatmentUpdate; 1998 Oct; 10(8):3-4. PubMed ID: 11365875
[TBL] [Abstract][Full Text] [Related]
13. Using ritonavir with indinavir in cases of virologic failure.
TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
[No Abstract] [Full Text] [Related]
14. Cure or control of HIV/AIDS?
Collins DO; Sakamoto A
Med Hypotheses; 1997 Jun; 48(6):489-90. PubMed ID: 9247891
[No Abstract] [Full Text] [Related]
15. [Anti-retroviral treatment. Approach to previously treated patients].
Antela A; Podzamczer D; Ruiz I; Parras F
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():24-30. PubMed ID: 9053023
[No Abstract] [Full Text] [Related]
16. A patient's guide to protease inhibitors.
Elperin A; Sax P
AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
[TBL] [Abstract][Full Text] [Related]
17. Sustiva added to three-drug combination.
AIDS Patient Care STDS; 1998 Oct; 12(10):803. PubMed ID: 11362030
[No Abstract] [Full Text] [Related]
18. Indinavir (Crixivan): new packaging and strength.
Res Initiat Treat Action; 1999 Apr; 5(2):33. PubMed ID: 11366284
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.
Duvivier C; Myrto A; Marcelin AG; Ghosn J; Ait-Mohand H; Schneider L; Agher R; Bricaire F; Costagliola D; Calvez V; Peytavin G; Katlama C
Antivir Ther; 2003 Dec; 8(6):603-9. PubMed ID: 14760894
[TBL] [Abstract][Full Text] [Related]
20. Spring cleaning in trial land.
Gilden D
GMHC Treat Issues; 1997 Mar; 11(3):4-7. PubMed ID: 11364275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
